Atherectomy Devices Market Grows Amid PAD Surge and Minimally Invasive Demand, Forecasting 6.3% CAGR by 2031 | Minnetronix Inc, Avinger Inc, Biomerics LLC, AngioDynamics Inc, RA Medical Systems, Straub Medical, Terumo Corporation

Atherectomy Devices market is estimated to grow at a CAGR of 6.3% during the forecast period 2024-2031.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/atherectomy-devices-market?sg

Key Market Drivers:
✅ Rising Prevalence of Peripheral Artery Disease (PAD)
The increasing global burden of PAD, particularly among aging populations and diabetic patients, is a primary driver. As patients seek less invasive options for arterial plaque removal, atherectomy devices have gained preference due to their efficacy and reduced recovery times.

✅ Technological Advancements
Continuous innovation in device design such as laser-based, orbital, and directional atherectomy has significantly improved procedural outcomes. These advancements allow for more precise plaque removal, lower complication rates, and reduced restenosis.

✅ Growing Demand for Minimally Invasive Procedures
Patients and physicians are increasingly inclined toward minimally invasive techniques due to shorter hospital stays, lower costs, and faster recovery. Atherectomy procedures offer a compelling alternative to traditional surgeries, making them attractive in both high- and low-income regions.

✅ Rising Healthcare Expenditure
Increased healthcare funding by governments and private entities, particularly in emerging economies, is expanding access to vascular interventions. This supports greater adoption of advanced devices in hospitals and ambulatory surgical centers.

Market Segments:
• By Product (Directional, Rotational, Laser, Orbital)
• By Application (Peripheral, Cardiovascular, Neurovascular)
• By End-User (Hospitals, Surgical Centers, Ascs, Research Laboratories, Academic Institutes)
• By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/atherectomy-devices-market?sg

Market Geographical Share:
✅ North America continues to dominate the atherectomy devices market, driven by a high prevalence of peripheral arterial disease (PAD) and favorable reimbursement structures. The United States, in particular, benefits from a strong clinical adoption of minimally invasive cardiovascular interventions, supported by advanced healthcare infrastructure and frequent technological upgrades in surgical tools.

✅ Europe holds a significant share, led by countries such as Germany, the UK, and France. The region's growth is fueled by rising awareness of early PAD diagnosis, increased healthcare spending, and a growing elderly population susceptible to vascular complications. Additionally, national screening programs and public health campaigns contribute to early detection and treatment.

✅ The Asia-Pacific region is witnessing rapid expansion, mainly due to an increasing burden of lifestyle diseases like diabetes and hypertension, which are closely linked to vascular disorders. Emerging economies such as China and India are investing in healthcare modernization, leading to improved access to interventional procedures. The growing pool of skilled professionals and increased government initiatives also support regional growth.

DataM Intelligence Opinion:
The atherectomy devices market is witnessing strong momentum, largely fueled by the rising prevalence of peripheral artery disease (PAD) and the global shift toward minimally invasive vascular interventions. As aging populations and diabetic patients grow in number, so does the demand for safer, more efficient plaque removal options. Atherectomy devices especially laser, orbital, and directional types have emerged as a preferred solution, offering clinical advantages such as lower restenosis rates, shorter recovery periods, and improved procedural precision. Technological innovation continues to be a central growth enabler, with next-gen devices driving broader clinical adoption across both developed and emerging markets.

Geographically, North America retains a leading position thanks to its advanced healthcare systems, favorable reimbursement policies, and high procedural volume. Europe follows with strong uptake supported by proactive screening programs and an aging population susceptible to vascular disease. Meanwhile,

Asia-Pacific stands out as the fastest-growing region due to the rapid rise in chronic conditions such as diabetes and hypertension, as well as increasing investment in healthcare infrastructure. At DataM Intelligence, we believe that manufacturers who focus on delivering cost-effective, minimally invasive atherectomy solutions tailored to both high-end and resource-constrained markets will be best positioned to lead in this evolving therapeutic landscape.

Market Key Players:
Key players are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson, and Company), Cardinal Health Inc., Koninklijke Philips NV, Medtronic, RA Medical Systems, Straub Medical, Terumo Corporation, Cardiovascular Systems Inc., Minnetronix Inc., Avinger Inc., Biomerics LLC, AngioDynamics Inc.

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

M&A Activity:

✅ Xtant Medical acquires Avinger: In March 2024, Xtant Medical completed the acquisition of Avinger, gaining access to its advanced image‐guided atherectomy technologies, including Avinger's Ocelot Catheter portfolio.

✅ Abbott acquires Cardiovascular Systems, Inc. (CSI): Abbott finalized the acquisition of CSI (developer of orbital atherectomy systems) in early 2023 for approximately USD 890 million, bolstering its vascular intervention offerings.

✅ OrbusNeich expands via acquisition in Taiwan (2025): Hong Kong's OrbusNeich acquired Taiwan Rich Medical in 2025 to strengthen its direct sales network in Taiwan a strategic expansion, though not exclusively in atherectomy devices, it reflects broader cardiovascular device scaling.

Strategic Partnerships & Collaborations:

✅ Medtronic & Biotronik collaboration:
In February 2024, Medtronic entered a collaboration with Biotronik to co‐develop and integrate Biotronik's vascular solutions with Medtronic's open technologies aiming to broaden treatment options and outcomes.

✅ Abbott distributes Diamondback 360 in Japan:
In April 2024, Abbott Medical Japan LLC took over distribution of the Diamondback 360 Coronary Orbital Atherectomy System in Japan under a definitive agreement. This leverages Abbott's network to expand Diamondback 360's regional reach.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.